_HOME | _RSS
View Article
LDL Cholesterol Level Predicts HCV Therapy Response in Patients With HIV Coinfection
Tuesday, June 24, 2008 - 07:57 AM - 6 months, 2 weeks ago - Presse spécialisée - Medscape HIV AIDS
Patients coinfected with hepatitis C virus (HCV) and HIV who have high pretreatment LDL cholesterol levels are more likely to respond to HCV therapy than are similar patients with low LDL cholesterol levels, according to a report in the May 11th issue of AIDS. Reuters Health Information
